Research Topics
Genomes and GenesSpecies | Francesco RodeghieroSummaryAffiliation: San Bortolo Hospital Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Treatment of von Willebrand diseaseFrancesco Rodeghiero
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Semin Hematol 42:29-35. 2005....
Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myelomaElisabetta Novella
Leuk Lymphoma 45:1497-9. 2004
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter studyF Rodeghiero
Hematology Department, S Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 3:2619-26. 2005..The aim of this study was the validation of the criteria defining a significant mucocutaneous-bleeding history in type 1 von Willebrand disease (VWD)...
Chronic immune thrombocytopenic purpura. New agentsF Rodeghiero
Department of Cell Therapy and Hematology, San Bortolo Hospital, Via Rodolfi 37, I 36100 Vicenza, Italy
Hamostaseologie 29:76-9. 2009..It seems however that a new paradigm in the treatment of ITP has been established where the focus is not on reducing platelet consumption but on increasing platelet production...
Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?Francesco Rodeghiero
Department of Cell Therapy and Haematology, San Bortolo Hospital, Vicenza, Italy
Br J Haematol 158:16-29. 2012..However, a splenectomy-sparing approach is also emerging for ITP, and recent guidelines recommend that this procedure is deferred until ≥ 12 months from ITP diagnosis, to allow sufficient time for possible remission...
Relevance of quantitative assessment of bleeding in haemorrhagic disordersF Rodeghiero
Department of Cell Therapy and Hematology, Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Haemophilia 14:68-75. 2008..Finally, Dr James will review the development of quantitative analysis in children, a particularly important and difficult application, but one that needs to be tackled urgently...
Laboratory issues in bleeding disordersF Rodeghiero
Department of Cell Therapy and Hematology, Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Haemophilia 14:93-103. 2008..The most needed areas concern VWD and platelet function disorders, which suffer from inadequate diagnostic standardization, hampering widespread diagnostic capability in both Western and non-Western countries...
Ifosfamide in hematological malignancies of adultsF Rodeghiero
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Oncology 65:85-93. 2003..Ifosfamide-based regimens are also being evaluated in the treatment of newly diagnosed patients in sequential, response-based protocols, using many non-cross-resistant drugs...
Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressinF Rodeghiero
Department of Cellular Therapy and Hematology, Thrombosis and Hemostasis Center, San Bortolo Hospital, Vicenza, Italy
Haemophilia 14:21-30. 2008....
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Blood 113:2386-93. 2009....
How I treat von Willebrand diseaseFrancesco Rodeghiero
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Blood 114:1158-65. 2009..On the basis of these results and through a series of illustrative examples, the clinician will be able to select the best approach for the optimal management of VWD, according to the patient's characteristics and clinical circumstances...
von Willebrand disease: still an intriguing disorder in the era of molecular medicineF Rodeghiero
Department of Hematology, Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Haemophilia 8:292-300. 2002....
How to estimate bleeding risk in mild bleeding disordersF Rodeghiero
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 5:157-66. 2007..Innovative approaches, combining into a single probability phenotypic and genetic data, could possibly estimate better the bleeding risk in specific disorders...
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)A Tosetto
San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 5:715-21. 2007..However, quantitative analysis of the importance of VWF antigen (VWF:Ag) and ristocetin cofactor activity (VWF:RCo) levels in the diagnosis is lacking...
Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteriaAlessandra Carobbio
Hematology Department, Ospedali Riuniti di Bergamo, Largo Barozzi 1, Bergamo, Italy
Blood 116:1051-5. 2010..The actuarial probability of thrombosis was significantly influenced by leukocytosis (P = .017) and not by platelet count, indicating that platelet number does not seem of prime relevance in the definition of ELN response...
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWDGiancarlo Castaman
Department of Haematology, San Bortolo Hospital, Vicenza, Italy
Br J Haematol 151:245-51. 2010....
The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell linesCarlo Visco
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Blood Cells Mol Dis 48:68-75. 2012..The strong synergistic effect of bendamustine and cytarabine on MCL cells provides a rationale for developing schedules combining these agents in the treatment of MCL...
Prolonged overall survival with second on-demand autologous transplant in multiple myelomaFrancesca Elice
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Am J Hematol 81:426-31. 2006..9% after the first ASCT but no deaths occurred after the second.Our experience suggests that elective up-front single ASCT followed by second ASCT after relapse or progression is a safe and effective global strategy to treat MM patients...
Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) geneElena Albiero
Department of Cellular Therapies and Haematology, San Bortolo Hospital, Vicenza, Italy
Haematologica 97:123-7. 2012..Identification of the disease-causing genes will be of critical importance for a better classification of familial and acquired erythrocytosis, offering additional insight into the erythropoietin regulating oxygen sensing pathway...
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemiaAlessandra Carobbio
Department of Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy
Blood 112:3135-7. 2008..These data challenge the theory that elevated platelet count increases thrombosis risk in ET and suggest prospective clinical trials to support this hypothesis...
Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearanceGiancarlo Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Thromb Haemost 105:647-54. 2011..In conclusion, similar to patients with type 1 VWD, also in patients with increased VWF clearance desmopressin maintains a major therapeutic role...
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective surveyMarco Ruggeri
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Blood 111:666-71. 2008..A high proportion of PV and ET surgeries was complicated by vascular occlusion (7.7%) or by a major hemorrhage (7.3%). Prospective investigations analyzing the optimal prophylaxis in these patients are suggested...
Intraindividual consistency of the activated protein C resistance phenotypeAlberto Tosetto
Hemophilia and Thrombosis Centre, Department of Haematology, S. Bortolo Hospital, Vicenza, Italy
Br J Haematol 126:405-9. 2004..4%) were carriers of the G20210A prothrombin allele. APC resistance not due to FV Leiden is a frequent and consistent phenotype in the general population, with a possibly strong genetic influence...
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWDGiancarlo Castaman
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Blood 111:3531-9. 2008..The presence of subtle multimeric abnormalities did not hamper potential clinically useful responses, as in typical type 1 VWD...
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)A Tosetto
San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 4:766-73. 2006..CONCLUSIONS: Quantitative analysis of bleeding symptoms is potentially useful for a more accurate diagnosis of type 1 VWD and to develop guidelines for its optimal treatment...
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell linesSilvia Castegnaro
Department of Cellular Therapies and Hematology, San Bortolo Hospital, Vicenza, Italy
Leuk Lymphoma 53:2262-8. 2012..01). Bendamustine and ara-c are highly synergistic on T- and B-cell lymphoma cells and cell lines, similar to MCL, overcoming resistance to the single agents...
A study on mutual interaction between cytokine induced killer cells and umbilical cord-derived mesenchymal cells: Implication for their in-vivo useKatia Chieregato
Advanced Cellular Therapy Laboratory, Department of Cellular Therapy and Hematology, San Bortolo Hospital, Via Rodolfi 37, 36100 Vicenza, Italy
Blood Cells Mol Dis 49:159-65. 2012..In the light of our observations, when CIK and UC-MSC will be used in clinical trials, timing and sequencing of their infusion should be considered...
Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissKatia Chieregato
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Cytotherapy 13:933-43. 2011..We analyzed the effect of four different medium supplements on the expansion and differentiation of adipose tissue-derived MSC (ADSC) in order to avoid the use of xenogeneic serum...
Assessing bleeding in von Willebrand disease with bleeding scoreAlberto Tosetto
Hematology Department, S Bortolo Hospital, 36100 Vicenza, Italy
Blood Rev 21:89-97. 2007..Therefore, BS represent a promising clinical tool for the analysis of bleeding in VWD, although further validation is warranted before an extensive use in clinical practice could be purported...
Association of plasma fibrinogen, C-reactive protein and G-455>A polymorphism with early atherosclerosis in the VITA Project cohortAlberto Tosetto
Department of Hematology, S Bortolo Hospital, Vicenza, Italy
Thromb Haemost 105:329-35. 2011..5 mg/dl. A persistent increase of plasma fibrinogen is associated with an increased risk of early atherosclerosis...
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter studyG Castaman
Department of Hematology, S. Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 4:2164-9. 2006..Desmopressin and/or tranexamic acid might be useful to prevent or treat bleeding in these cases...
Loss of the JAK2 intramolecular auto-inhibition mechanism is predicted by structural modelling of a novel exon 12 insertion mutation in a case of idiopathic erythrocytosisElena Albiero
Department of Cellular Therapy and Haematology, San Bortolo Hospital, Vicenza, Italy
Br J Haematol 142:986-90. 2008..Our model-based hypothesis provides a useful approach for the investigation of the phenotype-genotype relationship in myeloproliferative disorders involving JAK2...
Treatment outcome in a cohort of young patients with polycythemia veraMarco Ruggeri
Department of Cell Therapy and Hematology, San Bortolo Hospital, Viale Rodolfi 37, Vicenza, Italy
Intern Emerg Med 5:411-3. 2010..With this approach, vascular complications were no higher than in other published series, and secondary leukemia/myelodysplasia or cancer was not observed during a follow-up of 14 years...
Effect of platelet lysate on the functional and molecular characteristics of mesenchymal stem cells isolated from adipose tissueSilvia Castegnaro
Department of Cell Therapy and Haematology, San Bortolo Hospital, Vicenza, Italy
Curr Stem Cell Res Ther 6:105-14. 2011..They can be isolated from several tissues, but it is always necessary to expand them for clinical practice...
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemiaCarlo Visco
Department of Hematology, Ospedale San Bortolo, Vicenza, Italy
Blood 111:1110-6. 2008..Patients with CLL and IT had poorer survival than other patients with CLL (5-year overall survival 64% vs 82%, P < .001), and this effect was independent from common clinical prognostic variables...
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative casesFrancesca Scognamiglio
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Am J Hematol 83:326-9. 2008....
Hemostatic complications of angiogenesis inhibitors in cancer patientsFrancesca Elice
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Am J Hematol 83:862-70. 2008..Further studies are urgently required to better define the causal association of these new agents with hemostatic complications and to establish the best prophylactic strategy...
Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several yearsMaurizio Frezzato
Department of Cell Therapy and Hematology, S Bortolo Hospital, Vicenza, Italy
Am J Hematol 85:868-71. 2010..No additional rearrangements or mutations in the rearranged gene were found during follow-up. An identical clonal IGH gene rearrangement may precede CLL diagnosis by several years...
The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosisMarco Ruggeri
S. Bortolo Hospital, Vicenza, Italy
Ann Intern Med 139:470-5. 2003..However, the risks for developing polycythemia vera, essential thrombocythemia, or associated vascular complications in persons with erythrocytosis or thrombocytosis were low...
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO studyRoberto Raimondi
Department of Hematology, S Bortolo Hospital, Vicenza, Italy
Blood 120:1327-33. 2012..66, 064, and 0.59, respectively). We confirm the clinical utility of the HCT-CI score that could also identify patients at low NRM risk possibly benefiting from an HSCT-based treatment strategy...
Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approachAlberto Tosetto
Hematology Department, San Bortolo Hospital, Vicenza, Italy
Blood 111:3998-4003. 2008..0 (false-positive rate less than one-half). Validation of this approach and of its clinical utility is, however, required by analysis in other cohorts of well-characterized type 1 VWD patients...
A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor geneGiancarlo Castaman
Department of Hematology and Hemophilia, San Bortolo Hospital, I 36100 Vicenza, Italy
Thromb Res 105:135-8. 2002..These mutations are truly recessive and cause bleeding only in the compound heterozygous or homozygous state...
Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptorsCarlo Visco
Department of Hematology, Ospedale San Bortolo, Vicenza, Milano, Italy
Clin Cancer Res 18:1870-8. 2012..To assess biologic features related to the development of immune thrombocytopenia (ITP) in patients with chronic lymphocytic leukemia (CLL)...
Side effects of anti-angiogenic drugsFrancesca Elice
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Thromb Res 129:S50-3. 2012..So far, only few preliminary data are available on a strategy to prevent hemorrhage and thrombotic event...
Thrombosis associated with angiogenesis inhibitorsFrancesca Elice
Department of Cell Therapy and Haematology, San Bortolo Hospital, Via Rodolfi 37, 36100 Vicenza, Italy
Best Pract Res Clin Haematol 22:115-28. 2009..In addition, careful reporting of haemostatic complications during treatment with new anti-angiogenic drugs is warranted...
Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutationsGiancarlo Castaman
Department of Cell Therapy and Hematology, San Bortolo Hospital, I 36100 Vicenza, Italy
Haematologica 95:963-9. 2010..Pregnancy in von Willebrand's disease may carry a significant risk of bleeding. Information on changes in factor VIII and von Willebrand factor and pregnancy outcome in relation to von Willebrand factor gene mutations are very scanty...
Advances in the diagnosis and management of type 1 von Willebrand diseaseGiancarlo Castaman
Department of Cell Therapy and Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, 36100 Vicenza, Italy
Expert Rev Hematol 4:95-106. 2011....
Prognostic significance of CD56 antigen expression in acute myeloid leukemiaEros Di Bona
Department of Cellular Therapy and Hematology, Division of Hematology, San Bartolo Hospital, Vicenza, Italy
Haematologica 87:250-6. 2002..We investigated CD56 expression in a cohort of AML patients in order to assess its frequency and prognostic relevance...
Treatment practices in adults with chronic immune thrombocytopenia - a European perspectiveFrancesco Rodeghiero
Department of Cellular Therapy and Haematology, Ospedale S, Bortolo di Vicenza, Italy
Eur J Haematol 84:160-8. 2010..It also identified perceived shortcomings of existing therapies and the need to establish an evidence base for newer interventions that could potentially make lasting response to treatment with fewer adverse effects an achievable goal...
Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosisG Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Thromb Haemost 86:804-8. 2001..01-1.30). In conclusion, in subjects with G20210A mutation APC resistance is significantly increased, correlates with plasma prothrombin level and the carriers with the lowest APC resistance values have an increased risk of VTE...
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor VG Castaman
Department of Haematology and Haemophilia and Thrombosis Centre, San Bortolo Hospital, Vicenza, Italy
Br J Haematol 99:257-61. 1997..These data confirm that genotypic analysis is mandatory in patients with phenotypic severe APC resistance before these patients are definitely classified as homozygotes for FV Leiden and that further genotypic analysis is advisable...
Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemiaG Castaman
Department of Hematology and Hemophilia, San Bortolo Hospital, Vicenza, Italy
Haemophilia 15:533-7. 2009..Thrombotic events in patients with inherited severe hypofibrinogenemia are rather frequent, may be severe and not associated with the use of replacement therapy...
Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 familiesG Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Acta Haematol 121:106-10. 2009..We report our experience with 12 families with clearly recessive inheritance, but definitely measurable factor VIII and VWF, which is not typical for severe type 3 VWD...
Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevanceG Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 7:71-4. 2009..Recent evidence suggests that liver and spleen macrophages are responsible for VWF clearance through uptake and endocellular degradation, but it is still not known why some VWF mutants are more prone to increased clearance...
Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia AG Castaman
Department of Cell Therapy and Hematology, Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 7:1824-31. 2009..The relationship of the biologic response to desmopressin with the F8 mutation and physiological characteristics has been poorly investigated in patients with mild hemophilia A...
Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosisG Castaman
Department of Haematology and the Haemophilia and Thrombosis Centre, San Bortolo Hospital, Vicenza, Italy
Br J Haematol 106:232-6. 1999..01). Pseudohomozygosity for APC resistance carries a significantly higher risk for venous thromboembolism in comparison to normal subjects, but probably not in comparison to heterozygous FV Leiden carriers...
Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigationG Castaman
Department of Hematology, Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Thromb Haemost 82:1065-70. 1999..Further research should clarify whether in families with more severe clinical and laboratory phenotype a clear association with markers of VWF is found...
F8 mRNA studies in haemophilia A patients with different splice site mutationsG Castaman
Department of Cell Therapy and Hematology, Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Haemophilia 16:786-90. 2010..Both mutations were identified in severe HA. F8 mRNA analysis is a useful tool for the characterization of the mechanisms by which splice site mutations affect the phenotype, while in silico analysis may not be always reliable...
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemiaE Di Bona
Divisione di Ematologia, Ospedale San Bortolo, Vicenza Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Universita La Sapienza, Rome, Italy
Br J Haematol 108:689-95. 2000....
Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effectG Castaman
Department of Haematology and Haemophilia and Thrombosis Centre, San Bortolo Hospital, Vicenza, Italy
Br J Haematol 108:876-9. 2000..The patients responded well to desmopressin infusion. The C1130F mutation might have a dominant negative effect on the secretion of the normal protein that desmopressin would appear to overcome...
Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotypeG Castaman
Department of Cellular Therapy and Haematology, San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 8:2011-6. 2010..The R854Q mutation is the most frequent cause of this phenotype...
The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiencyG Castaman
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Blood Coagul Fibrinolysis 11:321-6. 2000..7-5.41; P = 0.1). In conclusion, the presence of the prothrombin mutation seems to increase the risk of VT carriers of protein S deficiency, although additional families are required to fully estimate the magnitude of risk...
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWDG Castaman
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Thromb Res 126:227-31. 2010..Accurate measurement of von Willebrand factor (VWF) is a critical requirement for the diagnosis of von Willebrand disease (VWD)...
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di ME Di Bona
Haematology Department, San Bortolo Hospital, Vicenza, Italy
Br J Haematol 107:330-4. 1999..Female gender was significantly associated with a poorer likelihood to respond (P = 0.0006). These data suggest that r-ATG is a safe and effective alternative to h-ALG for SAA patients unresponsive to first-line IS treatment...
Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutationG Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Am J Hematol 82:376-80. 2007..In conclusion, the mutation C2362F is frequently observed in compound heterozygosity with null alleles in patients with recessive VWD in the Veneto region and cause bleeding only in the compound heterozygous or homozygous state...
Spectrum of mutations in Albanian patients with haemophilia A: identification of ten novel mutations in the factor VIII geneG Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Haemophilia 13:311-6. 2007..These results further emphasize the extreme heterogeneity of the molecular basis of haemophilia A. The low prevalence of intron 22 inversion in Albanian patients with severe haemophilia A should be addressed by further studies...
ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literatureR Raimondi
Department of Haematology, BMT Unit, S Bortolo Hospital, Vicenza, Italy
Bone Marrow Transplant 34:321-9. 2004....
Molecular characterization of five Italian families with inherited severe factor XIII deficiencyG Castaman
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Haemophilia 14:96-102. 2008..Structural analysis shows that Pro186Leu mutation leads to the replacement of the rigid proline pyrrolidine ring by the larger and more flexible leucine side chain and Ser708Asn may probably disrupt the hydrogen bond with Ala291...
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defectG Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 4:357-60. 2006..No data on FVIII/VWF changes after desmopressin and during pregnancy in patients with phenotypic VWD Vicenza has been reported...
Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficienciesG Castaman
Department of Cell Therapy and Hematology, Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 8:2736-42. 2010..While VWD mutations acting at the protein level have been deeply investigated, fewer data are available on genetic defects affecting VWF mRNA...
Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myelomaElisabetta Novella
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Haematologica 87:1157-64. 2002..Furthermore, the sensitivity reached is up to 1 log higher than that of the conventional approach with nested-PCR, even though two steps of specificity are maintained...
Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysisMarco Ruggeri
Division of Hematology, S.Bortolo Hospital, Vicenza, Italy
Pediatr Blood Cancer 47:653-6. 2006..The study revealed confounding terminology and an unacceptable heterogeneity for clinical definitions relevant to management decisions and outcomes reporting...
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemiaMarco Ruggeri
Department of Hematology, S Bortolo Hospital, Vicenza, Italy
Am J Hematol 71:1-6. 2002..FV Leiden mutation is a risk factor for VTE before and at time of diagnosis and for VTE recurrences. Screening for FV Leiden may be considered to identify PV and ET patients at higher risk of recurrences...
Factor XI gene mutations in factor XI deficient patients of the Czech RepublicGiancarlo Castaman
Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
Am J Hematol 83:916-9. 2008....
Bleeding scores in inherited bleeding disorders: clinical or research tools?A Tosetto
Hematology Department, S Bortolo Hospital, Vicenza, Italy
Haemophilia 14:415-22. 2008....
Multiplex amplification and fluorimetric detection of short tandem repeats for mixed chimerism after bone marrow transplantDomenico Madeo
Department of Cell Therapy and Hematology, San Bortolo Hospital, via Rodolfi, 37, 36100 Vicenza, Italy
Leuk Lymphoma 44:1395-404. 2003..In conclusion, the proposed method is sufficiently simple, rapid, sensible, specific and cost effective for the evaluation of mixed chimerism after BM or PBSC transplant in a clinical setting...
Thalidomide and thrombosisFrancesco Rodeghiero
Department of Hematology, San Bortolo Hospital, Vicenza, Italy
Pathophysiol Haemost Thromb 33:15-8. 2003
Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessmentF Rodeghiero
Department of Hematology and Hemophilia, Thrombosis Center, San Bortolo Hospital, 36100 Vicenza, Italy
Best Pract Res Clin Haematol 14:321-35. 2001..We present a practical approach to diagnosis, based on scientific evidence and direct experience. The implications of the diagnosis of von Willebrand disease for the patient's quality of life are also considered...
Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA ProjectA Tosetto
Hematology Department, S. Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 1:1724-9. 2003..In 30% of VTE cases, at least two easily recognizable risk factors are present. Clinical assessment of risk factors remains the mainstay of VTE prevention...
Immune thrombocytopenia in lymphoproliferative disordersCarlo Visco
Division of Hematology, Department of Cell Therapy and Hematology, San Bortolo Hospital, Via Rodolfi 37, Vicenza 36100, Italy
Hematol Oncol Clin North Am 23:1261-74. 2009..A better understanding of the responsible mechanisms leading to ITP in each disease may allow for targeted treatment decisions, avoiding unwarranted immunosuppression and bleeding complications...
Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patientsEros Di Bona
Department of Haematology, Vicenza Hospital, Vicenza, Italy
Leuk Lymphoma 46:879-84. 2005..In spite of 12 HSCTs, there was no long-term survivor. 'ABC' salvage proved feasible and comparable to reported rescue chemotherapic regimens, but the achievement of cure in refractory/relapsing ALL remains an outstanding clinical task...
Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impactF Elice
Department of Hematology and Cell Therapy, San Bortolo Hospital, Vicenza, Italy
Thromb Res 125:S55-7. 2010....
Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA projectA Tosetto
Department of Hematology, S. Bortolo Hospital, Vicenza, Italy
J Thromb Haemost 3:1224-30. 2005..CONCLUSIONS: Age-specific reference limits provide better estimate of vascular risk in the population and correlation with established risk factors...
Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern ItalyC Visco
Department of Hematology, Ospedale S Bortolo, Vicenza, Italy
Ann Oncol 17:1434-40. 2006..Diffuse large B-cell lymphoma (DLBCL) has been correlated to hepatitis C virus (HCV) infection in few series, but characteristics and outcome of these patients remain undefined...
Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatmentGiancarlo Castaman
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy
Haematologica 88:94-108. 2003..These concentrates are clinically effective and safe, although they do not always correct the BT...
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)Sandra L Haberichter
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, USA
Blood 111:4979-85. 2008..The systematic assay of both plasma VWF and the VWF propeptide in moderately severe type 1 VWD patients may identify patients with a reduced VWF survival phenotype...
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adultsDonato Gemmati
Department of Biomedical Sciences and Advanced Therapies, Center Study for Hemostasis and Thrombosis, University of Ferrara, C so Giovecca 203, I 44100 Ferrara, Italy
Cancer Epidemiol Biomarkers Prev 13:787-94. 2004..These data are in accordance with the hypothesis that polymorphisms in the genes for folate and methionine metabolism might play a greater role in the occurrence of ALL than NHL by influencing DNA synthesis and/or DNA methylation...
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)Anne Goodeve
The Academic Unit of Haematology, University of Sheffield, United Kingdom
Blood 109:112-21. 2007..About one third of the type 1 VWD cases recruited could be reconsidered as type 2. The remaining group could be considered "true" type 1 VWD, although mutations were found in only 55%...
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experienceMaria Gabriella Mazzucconi
Dipartimento di Biotecnologia Cellulari ed Ematologia, Universita degli Studi di Roma La Sapienza, and Divisione di Ematologia, Ospedale Pediatrico Bambino Gesu, Rome, Italy
Blood 109:1401-7. 2007..A schedule of 3 cycles of HD-DXM pulses will be compared with standard prednisone therapy (eg, 1 mg/kg per day) in the next randomized Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) trial...
Epidemiology of von Willebrand disease in developing countriesAlok Srivastava
Department of Haematology, Christian Medical College, Vellore, India
Semin Thromb Hemost 31:569-76. 2005..Efforts are needed to develop national registries and make at least basic services for diagnosis and treatment widely available...
The elusive pathogenesis of von Willebrand disease VicenzaGiancarlo Castaman
Blood 99:4243-4; author reply 4244. 2002
Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow TransplantationTiziano Barbui
Divisione di Ematologia. Spedali Riuniti, Bergamo, Italy
Haematologica 89:215-32. 2004..Statements are graded according to the strength of the supporting evidence and uncertainty is explicitly declared...
Association of factor V deficiency with factor V HR2Elena M Faioni
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and Department of Internal Medicine, University of Milan, Italy
Haematologica 89:195-200. 2004..018). Double heterozygosity for HR2 and a factor V defect, including factor V deficiency, increased the thrombotic risk afforded by HR2...
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatmentsValerio De Stefano
Institute of Hematology, Catholic University, Largo Gemelli 8, 00168 Rome, Italy
Haematologica 93:372-80. 2008..Prior thrombosis is a well-established risk factor for re-thrombosis in polycythemia vera and essential thrombocythemia but scarce data are available on the rate of re-thrombosis and the optimal strategy for prevention of recurrence...
Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutationsGiancarlo Castaman
Haematologica 93:957-8. 2008
Mutations in the thrombomodulin gene are rare in patients with severe thrombophiliaElena M Faioni
Department of Internal Medicine, Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, I R C C S Maggiore Hospital, University of Milan, Via A di Rudin 8, 201458 Milan, Italy
Br J Haematol 118:595-9. 2002..Considering the lack of a phenotype and the costly screening procedure, we recommend that thrombomodulin defects be sought only for research purposes...
A new TMHA-DHPLC assay for the rapid mutation screening of JAK2 exon 14 in myeloproliferative disordersElena Albiero
Am J Hematol 83:603-4. 2008
First Italian families with homozygous R854Q type 2 N von Willebrand diseaseGiancarlo Castaman
Thromb Haemost 88:534-5. 2002
Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosisGuido Finazzi
Blood 101:3749. 2003
